Federal contract award

75H71121F80233

BLOOD BANK REAGENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeINDIAN HEALTH SERVICE
NAICS334516 — Analytical Laboratory Instrument Manufacturing
PSC6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicleV797D60637
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$95.9K
Current contract value$95.9K
Potential contract value / ceiling$95.9K
Start dateJul 1, 2021
Current end dateSep 30, 2025
Potential end dateSep 30, 2025
Latest award activityJul 14, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 14, 2026P00007$-16.4KDE-OB AND CLOSEOUT REMAINING FUNDS - FOR BLOOD BANK REAGENTS AND SUPPLIES AT THE CLAREMORE INDIAN HOSPITAL.
Jun 2, 2025P00006$5.3KLAB - P00006 / 75H71121F80233 EXERCISE AND CHANGE POP CLIN 10, OPTION YEAR 3, YEAR 4, TO 08/01/2025 - 09/30/2025 FOR BLOOD BANK REAGENTS AND SUPPLIES AT THE CLAREMORE INDIAN HOSPITAL.
Jul 11, 2024P00005$34.9KLAB - P00005 / 75H71121F80233 EXERCISE OPTION YEAR 3, YEAR 4, FOR BLOOD BANK REAGENTS AND SUPPLIES AT THE CLAREMORE INDIAN HOSPITAL. POP 08/01/2024 - 07/31/2025
Jun 13, 2024P00004$1.0KLAB - P00004 / 75H71121F80233 ADD Z488 FETALSCREEN II FMH KITS TO BE SHIPPED, 1/MONTH FOR REMAINING POP, (4 MONTHS APRIL - JULY), OPTION YEAR 2.
May 31, 2023P00003$0LAB - P00003 / 75H71121F80233 CORRECT LINE 8 TO COVID FUNDS AND THE U/C FOR LINE 9, 10 ON OY 3 & 4
Apr 11, 2023P00002$23.7KLAB - P00002 / 75H71121F80233 EXERCISE OPT YR 2 - BLOOD BANK REAGENTS
Jun 28, 2022P00001$23.7KBLOOD BANK REAGENTS
Jul 1, 20210$23.7KBLOOD BANK REAGENTS

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.